Meihua International Medical Technologies
MHUA
MHUA was delisted on the 8th of December, 2025.
2 hedge funds and large institutions have $135K invested in Meihua International Medical Technologies in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
0% more ownership
Funds ownership: 0% → 0% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$114K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$795 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Millennium Management
New York
| $134K | +$114K | +143 | New |
|
|
TRCT
2
Tower Research Capital (TRC)
New York
| $1K | +$795 | +1 | New |
|
MHUA Hedge Fund Activity: Q1 2022 in Review
2 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Meihua International Medical Technologies (MHUA) for Q1 2022, worth a combined $135K.
Buyers outnumbered sellers: 2 funds opened new MHUA positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Millennium Management, opening a new position worth an estimated $114K.
- 2 institutional investors held Meihua International Medical Technologies (MHUA) as of Q1 2022, up from 0 in Q4 2021.
- Funds reported $135K of Meihua International Medical Technologies stock for Q1 2022.
- 2 funds opened new Meihua International Medical Technologies positions in Q1 2022 and 0 closed out, a net change of +2 holders.
- The largest Meihua International Medical Technologies buyer in Q1 2022 was Millennium Management, an estimated $114K added.
Based on aggregated 13F filings for Q1 2022.